Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Cysteamine in Nephropathic Cystinosis
NCT02766855Completed
- Sponsor
- The Eye Center and The Eye Foundation for Research in Ophthalmology
- Start
- Jan 2004
- Primary completion
- Dec 2012
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of cysteamine in nephropathic cystinosis, sponsored by The Eye Center and The Eye Foundation for Research in Ophthalmology. Primary endpoints: Number of participants with improvement of photophobia at 48 months, Number of participants with improvement of corneal cystine crystals at 48 months and 1 more. Started Jan 2004; status: completed.
02
Drugs
cysteamine
03
Conditions
nephropathic cystinosis
Beyond the preview
Go deeper on NCT02766855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02766855.